Skip to main content
Equibles
SNY logo

SNY · Sanofi

Track SNY — free

Use SNY with AI

Ask our own analyst here, or connect this data to the AI you already use.

Ask ALVIS about SNY

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

ChatGPT Claude Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$45.83 +0.86 (+1.91%) At close · Aug 19
Market Cap
$107.84B
Shares
2.40B

Price & Indicators

Indicators
Price
Panels
Event markers
20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$45.83 Open$45.42 Day$45.42–46.02 52W close$41.33–52.34 Avg vol 30d3.2M Short int10.2M · 0.4% float · 2.7d Short vol40% DataJan 2020–Aug 2026

Up next

FQ3-26 quarter ends
~Sep 30, 2026 Est

Equibles Rating

blended score · not investment advice
Overall
Neutral
SellHoldBuy
Technical Buy Momentum Weak Sentiment Bearish Fundamentals Limited Quant / Vol Low
Market backdrop VIX 14.9 · calm Equity put/call 0.52
Technical
price trend
Buy
50 / 200-day cross No cross
Price vs 200-day avg −1%
below
Price vs 50-day avg +5%
above
RSI (14) 67
neutral
MACD trend Positive
52-week position 41%
mid-range
Volume (OBV) Confirms
volume backs price
Momentum
relative strength
Weak
1-month return +5%
trailing
6-month return −5%
trailing
YTD return −5%
this year
Relative strength −17%
vs S&P · 6-mo
Sentiment
smart money
Bearish
Trend (MA cross) No cross
50d $43 › 200d $46 — 200d above 50d
Institutional flow Distributing
-5% holders QoQ · +87 funds added
Insider flow Flat
No net insider activity over 90 days
Short interest Rising
0.43% of float · ▲ +38.3% MoM · 2.7 days cover
Volume signal Normal
Volume near normal
Institution breadth Steady
715 holders — mid 3-yr range
Squeeze score 57
elevated · 0–100
Fundamentals
Limited
Not enough data for a confident read.
Quant / Vol
risk profile
Low
Volatility 26%
annualized · 1-yr
Max drawdown −21%
past year
ATR 1.8%
of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Guidance & track record

Latest guidance · from the Earnings Call filed Jun 30, 2024
Scopes 1 and 2 reduction · by 2030 55%
Prior guidance period ended · from the Earnings Call filed Mar 31, 2025
Effective tax rate · full-year 2025 20%
Foreign exchange impact on sales · full-year 2025 -1.5%
Foreign exchange impact on EPS · full-year 2025 -2%

Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.

Technicals

trend & momentum for long-term holders Buy
0 · 5 · 2
50 / 200-day cross
No cross Neutral
Price vs 200-day avg
−1% Neutral
Price vs 50-day avg
+5% Bullish
RSI (14)
67 Neutral
MACD trend
Positive Bullish
52-week position
41% Neutral
Volume (OBV)
Confirms Neutral
Market signals — smart money & positioning
Bearish · 2 of 6
Trend (MA cross) No cross
50d $43 › 200d $46 — 200d above 50d
Institutional flow Distributing
-5% holders QoQ · +87 funds added
Insider flow Flat
No net insider activity over 90 days
Short interest Rising
0.43% of float · ▲ +38.3% MoM · 2.7 days cover
Volume signal Normal
Volume near normal
Institution breadth Steady
715 holders — mid 3-yr range
Price context
position in its 52-week range
Range low $41 Now $46 · 41% Range high $52
vs 200-day avg -1% vs 50-day avg +5%

Illustrative technical + ownership context — a signal mix, not investment advice.

Versus peers

Drug Manufacturers - General — same industry group
Open screener →
Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
SNY
Sanofi
this stock
$107.84B -5.4% — — 0.4%
LLY
ELI LILLY & Co
 $1.11T +19.1% +44.7% 39.7 1.0%
JNJ
Johnson & Johnson
 $658.89B +32.1% +6.0% 31.8 1.1%
ABBV
AbbVie Inc.
 $457.54B +16.4% +8.6% 73.1 1.3%
MRK
Merck & Co., Inc.
 $335.46B +44.6% +1.3% 108.8 1.1%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section
Ownership
Institutional Holders Reducing
Holders
715
% held
8.1%
Net QoQ
-19.9M sh
Top holder
Dodge & Cox
Held Float
View
Held by Funds
Fund positions
130
View
Short & Settlement
Short Interest Rising
Shares short
10.2M
Days to cover
2.7d
Change
+2.8M sh
View
Short Volume
Short vol %
40%
As of
Aug 19, 2026
Short Total
View
Fails to Deliver
FTD shares
284.4K
Value
$12.8M
As of
Jul 30, 2026
View
Off-Exchange
Off-exchange %
40.5%
Week of
Jul 13, 2026
Off-exch Lit
View
Smart Money
Congressional Trades Buy
Member
Alan Armstrong
Amount
$15.0K–$50.0K
Traded
Mar 30, 2026
View
Filings
SEC Filings
Latest
6-K
Filed
Aug 6, 2026
This year
31
View
Earnings & Events
Investor Relations
Upcoming events
1
View

Performance

5D 20D 120D MTD YTD
SNY +4.9% +4.7% -5.2% +6.4% -5.4%
SPY -0.4% +2.9% +11.6% +3.0% +12.8%
vs SPY +5.3% +1.8% -16.8% +3.4% -18.2%

Capital returns

Latest dividend
$2.422 / share · ex May 4, 2026
Raised 9.5%
Paid (TTM)
$2.422 / share · 1 payout
Dividend yield (TTM, derived)
— · history filling in

Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.

Key facts CIK 1121404 CUSIP 80105N105 13F (30d) 651 filings 608 filers Visit website Investor relations

Report a Problem

Category
Description
Email (optional, for follow-up)